Drug profile · INN
erythromycin ethylsuccinate
ERYTHROMYCIN ETHYLSUCCINATE
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
erythromycin ethylsuccinate (ERYTHROMYCIN ETHYLSUCCINATE) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Frequently asked questions
What is erythromycin ethylsuccinate?
erythromycin ethylsuccinate (ERYTHROMYCIN ETHYLSUCCINATE) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for erythromycin ethylsuccinate?
ERYTHROMYCIN ETHYLSUCCINATE is a marketed brand name for erythromycin ethylsuccinate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of erythromycin ethylsuccinate?
erythromycin ethylsuccinate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.